EHMT2 and cancer: Taken together, these results suggest that G9a-mediated methylation of RUNX3 under hypoxia enhances cancer cell proliferation by increasing cell cycle or cell division with possibility of suppressing apoptosis through inhibiting inflammasome-mediated apoptotic pathways, which might promote tumor growth.